Locations
Cambridge, MA, USA · Shanghai, China · Cambridge, MA, USA
industry
Pharmaceuticals
Size
11-50 employees
Stage
Other
founded in
2019
Rarestone Group is dedicated to building the first rare disease ecosystem in Greater China, to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable service supports. Rarestone Group consists of two business subsidiaries: Citrine Medicine and Zircon Health. Citrine Medicine is a pharmaceutical company focused on providing effective and affordable therapeutic solutions to rare disease patients in Greater China. Citrine Medicine currently focuses on four therapeutic areas: neurology, endocrinology, liver, kidney & metabolic diseases, and rare oncology. Citrine already has two assets, Wakix® and Alkindi®, in pre-NDA stage for rare diseases in neurology and endocrinology, respectively. Zircon Health is a “service company” and aims to build the first ecosystem for rare disease in China, providing a patient-centered service platform for full disease management by leveraging AI.
Something looks off?